Article Information
PubMed
Print ISSN
Online ISSN
History
- Received June 22, 2005
- Accepted August 12, 2005
- Published online October 26, 2005.
Article Versions
- Earlier version (August 15, 2005 - 08:39).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Kyung Sun Lee,
- Hee Sun Park,
- Seoung Ju Park,
- So Ri Kim,
- Kyung Hoon Min,
- Sun Mi Jin,
- Kwang-Hyun Park,
- Uh-Hyun Kim,
- Chan Young Kim and
- Yong Chul Lee
- Department of Internal Medicine, Airway Remodeling Laboratory, Research Center for Allergic Immune Diseases (K.S.L., H.S.P., S.J.P., S.R.K., K.H.M., S.M.J., Y.C.L.), and Department of Biochemistry (K.-H.P., U.-H.K.), Institute of Cardiovascular Research (U.-H.K.), and Department of Surgery (C.Y.K.), Chonbuk National University Medical School, Jeonju, South Korea
- Address correspondence to:
Dr. Yong Chul Lee, Department of Internal Medicine, Chonbuk National University Medical School, 634–18, Keumamdong, Jeonju, 561–712, South Korea; E-mail: leeyc{at}chonbuk.ac.kr
Statistics from Altmetric.com
Article usage
In this issue
A Prodrug of Cysteine, l-2-Oxothiazolidine-4-carboxylic Acid, Regulates Vascular Permeability by Reducing Vascular Endothelial Growth Factor Expression in Asthma
